Innate Pharma Net Income From Continuing Ops Over Time
| IPHA Stock | USD 1.60 0.02 1.27% |
Fundamental trend analysis helps separate temporary noise from persistent changes in Innate Pharma.
Review Innate Pharma Performance and Innate Pharma Correlation for additional context on Innate Pharma. The links provide additional reference points. Quarterly Earnings Growth -0.75 | Earnings Share -0.64 | Revenue Per Share | Quarterly Revenue Growth -0.61 | Return On Assets |
The market value of Innate Pharma is measured differently than book value, which reflects Innate accounting equity. Intrinsic value is an estimate of underlying worth, separate from trading price and book value. Market prices can move with sentiment and macro cycles, creating divergence from fundamentals. The valuation process compares these measures for perspective.
Note that Innate Pharma's intrinsic value and market price are different measures derived from different inputs. Reviewing financial results, valuation ratios, and competitive positioning helps frame the value discussion. By contrast, market price reflects the level where buyers and sellers transact.
Peer Comparison: Net Income From Continuing Ops
Compare Innate Pharma and related stocks such as Cardiff Oncology, Rani Therapeutics, and Milestone Pharmaceuticals Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRDF | -11.8 M | -11.8 M | -11.8 M | -11.8 M | -14.3 M | -27.5 M | -39.2 M | -24.9 M | -16.2 M | -16.4 M | -19.3 M | -28.3 M | -38.7 M | -40.8 M | -45.4 M | -45.9 M | -43.6 M |
| RANI | -26.6 M | -26.6 M | -26.6 M | -26.6 M | -26.6 M | -26.6 M | -26.6 M | -26.6 M | -26.6 M | -26.6 M | -16.7 M | -53.1 M | -63.3 M | -71.2 M | -56.6 M | -50.9 M | -53.5 M |
| MIST | -8.1 M | -8.1 M | -8.1 M | -8.1 M | -8.1 M | -8.1 M | -8.1 M | -8.1 M | -23.2 M | -55.2 M | -50 M | -42.9 M | -58.4 M | -59.3 M | -41.5 M | -37.4 M | -39.2 M |
| CGEN | -14.1 M | -14.1 M | -14.1 M | -14.1 M | -11.1 M | -20.2 M | -31.5 M | -37.1 M | -22.6 M | -27.3 M | -29.7 M | -34.2 M | -33.7 M | -18.8 M | -14.2 M | -12.8 M | -13.4 M |
| CRBP | -2.5 M | -2.5 M | -2.5 M | -2.5 M | -2.5 M | -8.9 M | -20 M | -32.4 M | -55.7 M | -71.5 M | -111.3 M | -45.6 M | -42.3 M | -47.5 M | -40.2 M | -36.2 M | -38 M |
| MOLN | -25.4 M | -25.4 M | -25.4 M | -25.4 M | -25.4 M | -25.4 M | -25.4 M | -25.4 M | -37 M | -36.3 M | -62.8 M | -63.8 M | 117.9 M | -59.6 M | -54 M | -62.1 M | -59 M |
| NVCT | -12.9 M | -12.9 M | -12.9 M | -12.9 M | -12.9 M | -12.9 M | -12.9 M | -12.9 M | -12.9 M | -12.9 M | -12.9 M | -12.9 M | -19.2 M | -22.3 M | -19 M | -26.4 M | -27.8 M |
| APLT | -4.3 M | -4.3 M | -4.3 M | -4.3 M | -4.3 M | -4.3 M | -4.3 M | -4.3 M | -16.5 M | -45.5 M | -94 M | -105.6 M | -82.5 M | -119.8 M | -105.6 M | -95.1 M | -99.8 M |
| ELTX | -12.3 M | -12.3 M | -12.3 M | -12.3 M | -12.3 M | -12.3 M | -12.3 M | -12.3 M | -12.3 M | -12.3 M | -15.7 M | -26.4 M | -28.2 M | -35.2 M | -51.9 M | -46.7 M | -44.4 M |
My Equities
My Current Equities and Potential Positions
| Innate Pharma | IPHA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 117, Avenue de |
| Exchange | NASDAQ Exchange |
USD 1.6
More Resources for Innate Stock Analysis
Understanding Innate Pharma typically begins with financial statements and long-term trend review. Key ratios help frame profitability, efficiency, and growth context for Innate Pharma Stock. Selected reports below provide context for Innate Stock:Review Innate Pharma Performance and Innate Pharma Correlation for additional context on Innate Pharma. The links provide additional reference points. Interested in buying Innate Stock? Our How to Buy Innate Pharma guide covers everything you need to know.Analysis related to Innate Pharma should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Innate Pharma technical stock analysis uses price and volume transformations to study behavior. The analysis highlights moving averages, RSI, and price correlation signals across the stock cycle.